Tenecteplase versus Alteplase as Bridging Thrombolysis before Mechanical Thrombectomy for Medium and Distal Vessel Occlusions
Authors:
- Luca ScarciaLSLuca Scarcia
- Gaspard GerschenfeldGGGaspard Gerschenfeld
- Sonia AlamowitchSASonia Alamowitch
- Nicolas ChaussonNCNicolas Chausson
- Jildaz CaroffJCJildaz Caroff
- Stéphane OlindoSOStéphane Olindo
- Gaultier MarnatGMGaultier Marnat
- Fernando PicoFPFernando Pico
- Wagih Ben HassenWHWagih Ben Hassen
- Pierre SenersPSPierre Seners
- Michel PiotinMPMichel Piotin
- Erwah KalsoumEKErwah Kalsoum
- 9 February 2026
- journal article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (8) , ajnr.A9219-2105
Abstract
The safety and efficacy of intravenous tenecteplase in acute ischemic stroke patients with primary medium and distal vessel occlusions (MDVO) selected for mechanical thrombectomy remain an area of active investigation. This observational study aimed to compare tenecteplase and alteplase in MDVO patients treated with mechanical thrombectomy (MT). A retrospective, propensity score-weighted analysis of two cohorts: patients with patients with primary MDVO who received bridging intravenous thrombolysis prior to MT, from the multicenter TETRIS registry treated with tenecteplase, and patients from a tertiary center cohort treated with alteplase. The primary outcome was a modified Rankin Scale (mRS) score of 0-2 at 90 days. Secondary outcomes included mortality, symptomatic intracranial hemorrhage (sICH), and early and final successful reperfusion rates, assessed using the extended Thrombolysis in Cerebral Infarction (eTICI) 2b-3 scale. We included 110 patients, 65 receiving tenecteplase and 45 receiving alteplase. mRS 0-2 at 90 days was achieved in 53.8% of tenecteplase-treated patients versus 48.9% of alteplase-treated patients (p = 0.41). Mortality and sICH rates were similar between groups (12.3% vs. 13.3%, p=0.68; 3.1% vs. 0%, p = 0.51, respectively). There was no significant difference in early reperfusion between tenecteplase and alteplase (40.2% vs. 31.1%; p = 0.53). Final successful reperfusion did not significantly differ (80.4% vs. 88.9%; p = 0.28). In MDVO, tenecteplase yielded comparable safety and functional outcomes to alteplase, without statistically significant differences in early or final reperfusion. In light of recent trials questioning the benefit of MT in MDVO, these data suggest comparable safety and functional outcomes between tenecteplase and alteplase as bridging thrombolysis prior to mechanical thrombectomy, within the limits of this observational study.Keywords
Funding Information
- DMU Neurosciences of the APHP. Sorbonne Université (ANR-10-IAIHU-06)
- DMU Neurosciences of the APHP. Sorbonne Université (CER-2021-1053)
This publication has 28 references indexed in Scilit:
- Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic StrokeJAMA, 2024
- Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion StrokeJAMA Neurology, 2023
- Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trialThe Lancet, 2023
- The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trialsJournal of Thrombosis and Thrombolysis, 2022
- Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trialThe Lancet, 2022
- Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trialThe Lancet, 2022
- Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trialThe Lancet Neurology, 2022
- Thrombectomy for Primary Distal Posterior Cerebral Artery Occlusion StrokeJAMA Neurology, 2021
- Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic StrokeJAMA, 2021
- Overlap WeightingJAMA, 2020